Forward Pharma CFO to Present at Two Upcoming Conferences in February
The Leerink Global Healthcare Conferenceto be held at the Waldorf Astoria in New York, New York. Joel Sendekwill present on Thursday, February 12th at 10:45 AM EDT.
The RBC Capital Markets'2015 Global Healthcare Conference to be held at the Palace Hotelin New York, New York. Joel Sendekwill present on Tuesday, February 24th at 8:30 AM EDT.
Investors and other interested parties may access a live audio webcast of the conference presentations by visiting
Our principal executive offices are located at Østergade 24A, 1, 1100 Copenhagen K,
|Forward Pharma A/S Media Contact:|
|Sharon Klahre, Director, Investor Relations|
|Forward Pharma USA, LLC|
|7 Skyline Drive|
|Hawthorne, NY 10532|
|The Ruth Group|
Forward Looking Statements:
Certain statements in this press release may constitute "forward-looking statements" of the Company within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to: statements which contain language such as: "believe," "expect," "hope," "would" and "potential." Forward-looking statements are predictions only which involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from those expressed in such statements. Many such risks, uncertainties and other factors are taken into account as part of our assumptions underlying these forward-looking statements and include, among others, the following: the Company's ability to obtain, maintain and defend issued patents with protective claims; the commencement of any patent interference or infringement action; the Company's ability to prevail in or obtain a favorable decision in any such action; and the Company's ability to recover damages in any such action; uncertainties relating to our development plans; risks and uncertainties related to the scope, validity; and the enforceability of our intellectual property rights in general and the impact on us of patents and other intellectual property of third parties. Given the uncertainties, assumptions and risk factors associated with this type of information, including those described above, investors are cautioned that the information may not be appropriate for other purposes.